Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.046 | 0.8 |